Sk. Chintala et al., INDUCTION OF MATRIX METALLOPROTEINASE-9 REQUIRES A POLYMERIZED ACTIN CYTOSKELETON IN HUMAN-MALIGNANT GLIOMA-CELLS, The Journal of biological chemistry, 273(22), 1998, pp. 13545-13551
Alterations in cytoskeleton and subsequent cell shape changes exert sp
ecific effects on the expression of various genes. Our previous result
s suggested that malignant human gliomas express elevated levels of ma
trix metalloproteinases compared with normal brain tissue and low grad
e gliomas. To understand the role of cell shape changes on matrix meta
lloproteinase expression in human glioma cells, we treated SNB19 cells
with cytochalasin-D, an inhibitor of actin polymerization, and colchi
cine-B, a tubulin inhibitor, in the presence of phorbol 12-myristate 1
3-acetate. Cytochalasin-D treatment of SNB19 cells resulted in the los
s of phorbol 12-myristate 13-acetate-induced matrix metalloproteinase-
9 (also known as gelatinase-B) expression and coincided with inhibitio
n of actin polymerization, resulting in cell rounding. Moreover, compa
red with monolayers, cells grown as spheroids or cell aggregates faile
d to express matrix metalloproteinase-9 in the presence of phorbol 12-
myristate 13-acetate. Matrix metalloproteinase-g expression was also i
nhibited by calphostin-C, a protein kinase inhibitor, suggesting the i
nvolvement of protein kinase C in matrix metalloproteinase-g expressio
n. Phorbol 12-myristate 13-acetate-induced invasion of SNB19 cells thr
ough Matrigel was inhibited by cytochalasin-D and calphostin-C. These
results suggest that the actin polymerization transduces signals that
modulate the expression of matrix metalloproteinase-9 expression and t
he subsequent invasion of human glioma cells.